Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Powders × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 3 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cisplatin 896 Cyclophosphamide 844 Carboplatin 840 Radiotherapy 784 Bevacizumab 741 Gemcitabine 712 pembrolizumab 665 Docetaxel 657 Paclitaxel 646 Oxaliplatin 614 Capecitabine 573 Fluorouracil 513 Rituximab 500 Nivolumab 441 Dexamethasone 434 Etoposide 413 Doxorubicin 400 Irinotecan 394 Leucovorin 339 Drug Therapy 338 Cytarabine 302 Cetuximab 296 Lenalidomide 288 Trastuzumab 283 Pemetrexed 281 durvalumab 265 Filgrastim 251 Magnetic Resonance Spectroscopy 241 Prednisone 238 Temozolomide 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03899077 2024-02-07

SAVE

Cancer Research Antwerp

Phase 2 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡